NM32-2668

· Numab Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NM32-2668, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]